Latest Novartis Stories
Syngenta corn lawsuits consolidated as a multidistrict litigation in Kansas now number more than 200 actions; attorneys handling Syngenta Viptera lawsuits for the Onder Law Firm provide no-obligation
DUBLIN, January 27, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/n68kp7/pediatric_drugs) has announced the addition of the "Pediatric
With today's approval, Bexsero is now licensed in 37 countries; since first approval in Europe, over 1 million doses have been distributed worldwide BASEL, Switzerland, Jan.
- Array to receive global rights from Novartis to innovative BRAF inhibitor - BOULDER, Colo., Jan. 23, 2015 /PRNewswire/ -- Array BioPharma Inc.
Ohio Farmers Join Other Corn Growers Who Have Filed Syngenta GMO Corn Seed Lawsuits Over The Company’s Exporting of its Genetically Modified Corn Seed Without First Receiving China’s Approval
NEW HAVEN, Conn., Jan.
- Novartis returns Alisporivir (DEB025) to Debiopharm Group(TM) including all rights for HCV and other indications - LAUSANNE, Switzerland, January 12, 2015 /PRNewswire/ --
- The word or words serving to define another word or expression, as in a dictionary entry.